Literature DB >> 28589452

On-demand microbicide products: design matters.

Sravan Kumar Patel1,2, Lisa Cencia Rohan3,4.   

Abstract

Sexual intercourse (vaginal and anal) is the predominant mode of human immunodeficiency virus (HIV) transmission. Topical microbicides used in an on-demand format (i.e., immediately before or after sex) can be part of an effective tool kit utilized to prevent sexual transmission of HIV. The effectiveness of prevention products is positively correlated with adherence, which is likely to depend on user acceptability of the product. The development of an efficacious and acceptable product is therefore paramount for the success of an on-demand product. Acceptability of on-demand products (e.g., gels, films, and tablets) and their attributes is influenced by a multitude of user-specific factors that span behavioral, lifestyle, socio-economic, and cultural aspects. In addition, physicochemical properties of the drug, anatomical and physiological aspects of anorectal and vaginal compartments, issues relating to large-scale production, and cost can impact product development. These factors together with user preferences determine the design space of an effective, acceptable, and feasible on-demand product. In this review, we summarize the interacting factors that together determine product choice and its target product profile.

Entities:  

Keywords:  Acceptability; Anogenital; HIV; On-demand products; Rectal microbicides; Vaginal microbicides

Mesh:

Substances:

Year:  2017        PMID: 28589452      PMCID: PMC5658236          DOI: 10.1007/s13346-017-0385-4

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  109 in total

Review 1.  Nanomedicine in the development of anti-HIV microbicides.

Authors:  José das Neves; Rute Nunes; Francisca Rodrigues; Bruno Sarmento
Journal:  Adv Drug Deliv Rev       Date:  2016-01-30       Impact factor: 15.470

2.  Assessing microbicide acceptability: a comprehensive and integrated approach.

Authors:  Kathleen M Morrow; Monica S Ruiz
Journal:  AIDS Behav       Date:  2007-06-26

3.  Pharmaceutical quality by design: product and process development, understanding, and control.

Authors:  Lawrence X Yu
Journal:  Pharm Res       Date:  2008-01-10       Impact factor: 4.200

4.  Variations in microbicide gel acceptability among young women in the USA and Puerto Rico.

Authors:  Rebecca Giguere; Alex Carballo-Diéguez; Ana Ventuneac; Marina Mabragaña; Curtis Dolezal; Beatrice A Chen; Jessica A Kahn; Gregory D Zimet; Ian McGowan
Journal:  Cult Health Sex       Date:  2011-11-15

5.  Expanded safety study of Praneem polyherbal vaginal tablet among HIV-uninfected women in Pune, India: a phase II clinical trial report.

Authors:  S N Joshi; S Dutta; B K Kumar; U Katti; S Kulkarni; A Risbud; S Mehendale
Journal:  Sex Transm Infect       Date:  2008-04-21       Impact factor: 3.519

6.  Women's preferences for vaginal antimicrobial contraceptives. V: attitudes of Brazilian women to the insertion of vaginal products.

Authors:  Ellen Hardy; Karla S de Pádua; Eliana Maria Hebling; Maria José Duarte Osis; Lourens J D Zaneveld
Journal:  Contraception       Date:  2003-05       Impact factor: 3.375

Review 7.  Current strategies for sustaining drug release from electrospun nanofibers.

Authors:  Shih-Feng Chou; Daniel Carson; Kim A Woodrow
Journal:  J Control Release       Date:  2015-09-09       Impact factor: 9.776

Review 8.  Rethinking gender, heterosexual men, and women's vulnerability to HIV/AIDS.

Authors:  Jenny A Higgins; Susie Hoffman; Shari L Dworkin
Journal:  Am J Public Health       Date:  2010-01-14       Impact factor: 9.308

Review 9.  Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies.

Authors:  Marie-Claude Boily; Rebecca F Baggaley; Lei Wang; Benoit Masse; Richard G White; Richard J Hayes; Michel Alary
Journal:  Lancet Infect Dis       Date:  2009-02       Impact factor: 25.071

Review 10.  Drug delivery and nanoparticles:applications and hazards.

Authors:  Wim H De Jong; Paul J A Borm
Journal:  Int J Nanomedicine       Date:  2008
View more
  6 in total

1.  Drug delivery in female reproductive health.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

2.  Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir Against Repeated Rectal Simian Human Immunodeficiency Virus Exposures in Macaques.

Authors:  Charles W Dobard; Natalia Makarova; Rolieria West-Deadwyler; Andrew Taylor; Chuong Dinh; Amy Martin; Jonathan Lipscomb; James Mitchell; George Khalil; Gerardo Garcia-Lerma; Walid Heneine
Journal:  J Infect Dis       Date:  2018-09-08       Impact factor: 5.226

Review 3.  Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.

Authors:  Ignacio Rodríguez-Izquierdo; Daniel Sepúlveda-Crespo; Jose María Lasso; Salvador Resino; Ma Ángeles Muñoz-Fernández
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-12

4.  Potential of mucoadhesive chitosan glutamate microparticles as microbicide carriers - antiherpes activity and penetration behavior across the human vaginal epithelium.

Authors:  Emilia Szymańska; Małgorzata Krzyżowska; Krzysztof Cal; Barbara Mikolaszek; Jakub Tomaszewski; Sławomir Wołczyński; Katarzyna Winnicka
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

5.  User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences.

Authors:  Kate M Guthrie; Rochelle K Rosen; Sara E Vargas; Melissa L Getz; Lauren Dawson; Melissa Guillen; Jaime J Ramirez; Marc M Baum; Kathleen L Vincent
Journal:  PLoS One       Date:  2018-05-14       Impact factor: 3.240

6.  Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo.

Authors:  Nina Derby; Manjari Lal; Meropi Aravantinou; Larisa Kizima; Patrick Barnable; Aixa Rodriguez; Manshun Lai; Asa Wesenberg; Shweta Ugaonkar; Keith Levendosky; Olga Mizenina; Kyle Kleinbeck; Jeffrey D Lifson; M Melissa Peet; Zachary Lloyd; Michael Benson; Walid Heneine; Barry R O'Keefe; Melissa Robbiani; Elena Martinelli; Brooke Grasperge; James Blanchard; Agegnehu Gettie; Natalia Teleshova; José A Fernández-Romero; Thomas M Zydowsky
Journal:  Nat Commun       Date:  2018-09-24       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.